Blueprint Investment Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,871
Closed -$352K 114
2024
Q4
$352K Buy
3,871
+1,413
+57% +$135K 0.06% 150
2024
Q3
$255K Sell
2,458
-806
-25% -$82.1K 0.05% 146
2024
Q2
$317K Sell
3,264
-316
-9% -$29.1K 0.07% 104
2024
Q1
$322K Buy
3,580
+170
+5% +$14.4K 0.06% 113
2023
Q4
$272K Buy
+3,410
New +$256K 0.07% 107
2023
Q3
Sell
-5,352
Closed -$412K 114
2023
Q2
$412K Buy
+5,352
New +$414K 0.15% 98
2023
Q1
Sell
-6,504
Closed -$512K 241
2022
Q4
$512K Buy
6,504
+2,662
+69% +$200K 0.11% 126
2022
Q3
$270K Sell
3,842
-275
-7% -$21.6K 0.07% 110
2022
Q2
$330K Buy
4,117
+2,578
+168% +$202K 0.09% 105
2022
Q1
$117K Buy
+1,539
New +$122K 0.03% 195

Other funds holding CL

Blueprint Investment Partners's CL Position: Q1 2025 in Review

Blueprint Investment Partners sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 3,871 shares — an estimated $352K sold.

Blueprint Investment Partners first reported a position in CL in Q1 2022 and held it in 10 quarters. The position peaked at $512K in Q4 2022. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Blueprint Investment Partners reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Blueprint Investment Partners sold 3,871 Colgate-Palmolive shares in Q1 2025, an estimated $352K.
  • Blueprint Investment Partners first reported a position in Colgate-Palmolive in Q1 2022 and held it in 10 quarters.
  • Blueprint Investment Partners's Colgate-Palmolive position peaked at $512K in Q4 2022.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Blueprint Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.